糖尿病黄斑浮腫：疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 11
3.3.1 US 12
3.3.2 5EU 12
3.3.3 Japan 13
3.4 Forecast Methodology 13
3.4.1 Sources Used 15
3.4.2 Sources Not Used 17
3.4.3 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetes 18
3.4.4 Forecast Assumptions and Methods — Diagnosed Prevalent Cases of Diabetic Retinopathy 21
3.4.5 Forecast Assumptions and Methods – Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 22
3.4.6 Forecast Assumptions and Methods – Total Prevalent Cases of ME following BRVO and CRVO 23
3.5 Epidemiological Forecast for Macular Edema (2013-2023) 25
3.5.1 Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 25
3.5.2 Age-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 27
3.5.3 Sex-Specific Diagnosed Prevalent Cases of DME in the Diagnosed Diabetic Retinopathy Population 29
3.5.4 Total Prevalent Cases of ME following BRVO 31
3.5.5 Age-Specific Total Prevalent Cases of ME following BRVO 33
3.5.6 Sex-Specific Total Prevalent Cases of ME following BRVO 35
3.5.7 Total Prevalent Cases of ME following CRVO 37
3.5.8 Age-Specific Total Prevalent Cases of ME following CRVO 39
3.5.9 Sex-Specific Total Prevalent Cases of ME following CRVO 41
3.6 Discussion 43
3.6.1 Epidemiological Forecast Insight 43
3.6.2 Limitations of the Analysis 44
3.6.3 Strengths of the Analysis 45
4 Appendix 46
4.1 Bibliography 46
4.2 About the Authors 50
4.2.1 Epidemiologists 50
4.2.2 Reviewers 50
4.2.3 Acting Director of Epidemiology 52
4.2.4 Global Head of Healthcare 52
4.3 About GlobalData 53
4.4 About EpiCast 53
4.5 Disclaimer 54